Stay safe and minimise disruptions
COVID Rapid Antigen Test
Results in 15 minutes.
Gardian Technologies and SureScreen Australia are able to supply Rapid Antigen Tests at your business.
The rapid test kit identifies COVID-19 antigen present in a swab sample and gives a qualitative yes/no result within 15 minutes.
Gardian has developed a purpose built application to ensure the correct procedures are in place including handling of medical information and reporting at your point of care wherever rapid antigen tests are being undertaken.
What is a rapid antigen test?
99.5% accurate using swab.
Identifies infection in asymptomatic cases.
Allows for cost-effective repeat testing.
Fast turn around with results in 15 minutes.
Flexibility to test anywhere, any time.
Ideal as a triage and screening tool.
Bolster your COVID-19 safety plan.
Any suitably qualified healthcare professional can administer test.
Provide peace of mind.
Minimise business disruptions.
A Rapid Antigen Test is a test that looks for COVID antigens from a small swab sample.
It can be done anywhere at anytime by a suitably qualified individual and does not need to go to the pathology lab for results.
Results are quick, and the procedure requires a small swab sample.
Note: This product is not for general sale.
Information pertaining to and procurement of this product is restricted and conditional to individuals and entities that meet and comply with TGA regulations for COVID-19 test kits included on the ARTG.
How does a rapid antigen test work?
Two kinds of coronavirus tests look for viral material. These two tests include a Nucleic-acid-based test (or PCR test) and an Antigen test.
The third kind of test is an Antibody test, which examines the immune response to infection.
The PCR test requires a pathology lab to process the test result, whereas a Rapid Antigen Test or Antibody Test can be done outside of a lab, at the point of care, on site at your workplace.
About SureScreen Diagnostics Rapid Test Kits
SureScreen's COVID-19 rapid test identifies COVID-19 present in a swab sample and gives a qualitative yes/no result within 15 minutes.
The test is perfect for screening quickly at the patient side for the presence of COVID-19. The test can be used as a companion to the antibody test to increase the window of detection.
Implementing rapid screening for COVID-19 has huge time and cost savings when compared to, or integrated into, laboratory screening, and will help to control the spread of the virus by identifying active infection rapidly and accurately.
A swab is used to sample from either the nose or throat (nasopharyngeal or oropharyngeal sample) and introduced into the test cassette by suspension in a buffer solution.
Frequent testing increases the certainty of detecting a positive result regardless of prevalence. At risk cohorts have a higher prevalence than the general population in Australia.
SureScreen have been providing proactive, bespoke diagnostic solutions to organisations for nearly 25 years. Believing early diagnosis is key to preventing disruption to both time and finances, SureScreen deliver tailored services and products across the UK, Europe and APAC region.
SureScreen is an award-winning business that provides quality rapid diagnostic equipment and services around the globe with test kits manufactured for over 53 countries. SureScreen is the exclusive manufacturer of test kits for the UK Government and have manufactured over 30 million test kits for the NHS and Public Health England (PHE) for mass screening activities.